SPOM (SPO Global) Risk Assessment

View and export this data going back to . Start your Free Trial

What is SPO Global Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of SPO Global is: No Data: Cannot be evaluated.

Competitive Comparison of SPO Global's Risk Assessment

For the Conglomerates subindustry, SPO Global's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SPO Global's Risk Assessment Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, SPO Global's Risk Assessment distribution charts can be found below:

* The bar in red indicates where SPO Global's Risk Assessment falls into.

SPO Global (OTCPK:SPOM) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

SPO Global Risk Assessment Related Terms

Thank you for viewing the detailed overview of SPO Global's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

SPO Global Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » SPO Global Inc (OTCPK:SPOM) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jinan Pharma Valley, 27th Floor Block A J, Shandong, CHN, 33634

Website

http://www.gerpanghealthcare.com

SPO Global Inc is a holding company whose strategic plan is to acquire interests in emerging young businesses and provide financing, advice and guidance to assist them in realizing their potential. The Company is implementing an acquisition roll-up model of acquiring sales, marketing, and manufacturing businesses. The business scope of the company includes bio-pharmaceutical Research and development, development and sales of medical informatization software, medical high-tech introduction, production and sales of medical quality supplies, dietary supplements, and medicine, as well as agents and sales of medical equipment supplies.

Executives

Jeffrey Louis Feuer	officer: Chief Financial Officer	21860 BURBANK BLVD SUITE 380, WOODLAND HILLS CA 91367
Richard H Ryan	officer: Chief Operating Officer	21860 BURBANK BLVD., NORTH BUILDING SUITE 380, WOODLAND HILLS CA 91367
Michael Braunold	director, officer: Chief Executive Officer	C/O AUBIENT CORP, 1033 BECON ST, BROOKLINE MA 02446
Sidney Braun	director	SUITE 404, 6711 MISSISSAUGA ROAD, MISSISSAUGA A6 L5N 2W3
Pauline Dorfman	director	183 REINER ROAD, TORONTO A6 M3H 2L8
Israel Sarussi	10 percent owner, officer: Chief Technology Officer	C/O SPO, SUITE 380, 21860 BURBANK BLVD., WOODLAND HILLS CA 91367